HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prestige beauty insight from NPD

This article was originally published in The Rose Sheet

Executive Summary

From January through September of this year, 29% of foundations were sold in compact form, 31% of those as a crème to powder formula, and 36% of foundations offer SPF protection, up 11% from the same period last year, according to new data from the NPD Group, released Nov. 23. The firm also found that 33% of all blushes are bronzers, and sales of bronzers are down 1% while general blush sales fell 5% in the first nine months of the year. Sales of palettes with five or more eye shadow shades grew 23% while the overall eye shadow category decreased 12%. Market research firm also has data on lip products/plumpers

You may also be interested in...



Cosmetic/Skin-Care Combinations Advised With Traditional Makeup Down

Use of makeup products among women ages 18 to 64 is down 5 percent from 2008, with women looking to simplify their beauty routines, according to a new study from the NPD Group

Impella Safety Update: Data Supports Pump For Qualified Patients

Updated data from a postmarket study of Abiomed’s Impella RP right-heart pump further supports the device’s safety for a specific patient population.

Quality, Safety, MDSAP A Focus For Medtech In New USMCA Trade Agreement

The new US-Mexico-Canada (USMCA) trade agreement includes language on enhancing regulatory compatibility between the three countries by recognizing quality systems audits performed under the Medical Device Single Audit Program (MDSAP). It also stipulates that each trading partner “consider its resources and technical capacity” in ensuring the safety, effectiveness and quality of devices – and more. Medtech industry advocacy group AdvaMed is praising the deal, reached by the three countries on 10 December.

UsernamePublicRestriction

Register

RS016583

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel